SalvaRx Group Plc Company Profile (LON:3LEG)

About SalvaRx Group Plc

SalvaRx Group Plc logoSalvaRx Group plc, formerly 3Legs Resources plc, is an investing company. The Company is engaged in drug discovery and development, focused on immune-oncology. The Company's segment is appraisal of investment targets meeting the Company's investment policy. The Company is focused on evaluation and assessment of investment opportunities in line with the investment policy. Its product is IMM60. It expects the study to evaluate approximately three treatment groups: a control arm using the standard of care (an anti-programmed death (PD)-1 therapy), a trial arm using iOX Therapeutics Ltd's drug (IMM60), and a third arm that will test the combination of IMM60 and an anti-PD1 therapy. 3Legs Management Services US LLC is the subsidiary of the Company.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: 3LEG
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $0
  • 200 Day Moving Average: $0
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for SalvaRx Group Plc (LON:3LEG) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SalvaRx Group Plc (LON:3LEG)
Show:
DateFirmActionRatingPrice TargetDetails
2/2/2016Northland SecuritiesReiterated RatingCorporateView Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for SalvaRx Group Plc (LON:3LEG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SalvaRx Group Plc (LON:3LEG)
Current Year EPS Consensus Estimate: $-3.00 EPS

Dividends

Dividend History for SalvaRx Group Plc (LON:3LEG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for SalvaRx Group Plc (LON:3LEG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for SalvaRx Group Plc (LON:3LEG)
DateHeadline
News IconAdmission to AIM of SalvaRx Group plc (LON:3LEG)
www.cooley.com - February 8 at 8:19 PM
morningstar.co.uk logoSalvaRx Clarifies Magazine Article About Intensity Therapeutics Trials (LON:3LEG)
www.morningstar.co.uk - February 3 at 3:05 PM
4-traders.com logoSalvaRx : Clarifies Magazine Article About Intensity Therapeutics Trials (LON:3LEG)
www.4-traders.com - February 2 at 8:05 PM
News IconHalf-year Report - Satellite PR News (press release) (LON:3LEG)
satprnews.com - December 1 at 1:16 AM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City Churchill Mining,SalvaRx Group, Valrix, PhotonStar, Rockwell Diamonds (LON:3LEG)
www.proactiveinvestors.co.uk - September 13 at 8:01 AM
stockmarketwire.com logoSalvaRx pre-tax losses widen (LON:3LEG)
www.stockmarketwire.com - September 13 at 8:01 AM
4-traders.com logoSalvaRx : Goes Deeper Into Red On Cost Of Reversal Into 3 Legs Resources (LON:3LEG)
www.4-traders.com - September 13 at 8:01 AM
morningstar.co.uk logoSalvaRx Expects To Start Clinical Trial This Year, Posts Annual Loss (LON:3LEG)
www.morningstar.co.uk - June 27 at 8:01 AM
4-traders.com logo3Legs Resources : SalvaRx Final Results (LON:3LEG)
www.4-traders.com - June 27 at 8:01 AM

Social

What is SalvaRx Group Plc's stock symbol?

SalvaRx Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "3LEG."

How do I buy SalvaRx Group Plc stock?

Shares of SalvaRx Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of SalvaRx Group Plc stock cost?

One share of SalvaRx Group Plc stock can currently be purchased for approximately GBX 0.32.


Last Updated on 2/27/2017 by MarketBeat.com Staff